On Monday, Shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO), surged 26.19% to $8.19.
Inovio Pharmaceuticals stated financial results for the quarter ended June 30, 2015.
Total revenue was $5.3 million and $10.5 million for the three and six months ended June 30, 2015, contrast to $3.8 million and $6.2 million for the same periods in 2014.
Total operating expenses were $20.4 million and $33.9 million for the three and six months ended June 30, 2015, contrast to $14.0 million and $26.3 million for the same periods in 2014.
The net loss attributable to common stockholders for the three and six months ended June 30, 2015, was $6.2 million, or $0.09 per share, and $16.8 million, or $0.26 per share, contrast to $10.7 million, or $0.18 per share, and $21.5 million, or $0.37 per share, for the same periods in 2014.
Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases.
Shares of Delta Air Lines, Inc. (NYSE:DAL), declined -0.06% to $46.32, during its last trading session.
Delta Air Lines, has scrapped a number of its flights to Dubai this winter in an apparent nod to how competition with three Gulf carriers is hurting its business, according to Reuters.
Delta, the second-largest U.S. passenger carrier, will fly nonstop to Dubai from its Atlanta hub between four and five times per week starting Oct. 1, down from daily service this summer. The airline revised its plan on Friday to reflect the change, part of a broader 15-to-20 percent cut in capacity to the Middle East and Africa that Delta declared in April. Reuters Reports
“The reduction comes amid overcapacity on U.S. routes to the Middle East operated by government-owned and subsidized airlines,” Delta spokesman Trebor Banstetter said in a statement, noting that daily service would return in the spring of 2016.
Delta Air Lines, Inc. provides planned air transportation for passengers and cargo worldwide. The company operates in two segments, Airline and Refinery. Its route network comprises various gateway airports in Amsterdam, Detroit, Los Angeles, Minneapolis-St. Paul, New York-LaGuardia, New York-JFK, Paris-Charles de Gaulle, Salt Lake City, Seattle, and Tokyo-Narita.
Finally, Skyworks Solutions Inc. (NASDAQ:SWKS), ended its last trade with 3.02% gain, and closed at $91.03.
Skyworks Solutions declared that it will be the exclusive provider of RF content powering D-Links next generation 802.11ac Wave 2 devices. The AC5300 (DIR-895L/R) and AC3150 (DIR-885L/R) ultra Wi-Fi routers support tri-band 2.4 and 5 GHz technology, multiple user MIMO and deliver wireless speeds up to 5.3 Gbps and 3.2 Gbps, respectively. The DIR-895L/R is the world’s fastest router, facilitating uninterrupted, high definition multimedia streaming in the home.
According to a May 2015 Cisco Visual Networking Index Forecast, by 2019 fixed networking devices such as routers will handle about 82 percent of all consumer Internet traffic, with total Internet traffic growing by a compounded annual growth rate of 33 percent from 2015 to 2019. By leveraging advanced networking technology from Skyworks and D-Link, users are able to support applications and devices with ever increasing bandwidth demands.
Skyworks Solutions, Inc., together with its auxiliaries, designs, develops, manufactures, and markets analog and mixed signal semiconductors worldwide. Its product portfolio comprises amplifiers, attenuators, battery chargers, circulators, DC/DC converters, demodulators, detectors, diodes, directional couplers, filters, front-end modules, hybrids, infrastructure radio frequency subsystems, isolators, LED drivers, mixers, modulators, optocouplers, optoisolators, phase shifters, phase locked loops/synthesizers/VCOs, power dividers/combiners, power administration devices, receivers, switches, technical ceramics, and voltage regulators.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
